Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe record history now includes updates for Study Design, Study Status, and Recruitment Status, reflecting new structured status information for the trial. The study's status has been changed from Active, not recruiting to Completed.SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe history now shows a new latest revision, v3.6.5, added to the list. The previous revision v3.6.4 has been removed from the history.SummaryDifference0.0%

- Check51 days agoChange DetectedA new revision label (v3.6.4) was added to the history, replacing the previous v3.6.3 label. This reflects an update to the page's revision metadata rather than changes to the study content.SummaryDifference0.0%

- Check73 days agoChange DetectedThe revision label in the page footer changed to v3.6.3, indicating a minor site build update rather than a content change.SummaryDifference0.0%

- Check80 days agoChange DetectedAn administrative revision entry (v3.6.2) was added to the study history and an older revision (v3.6.0) was removed, reflecting metadata maintenance of the record.SummaryDifference0.2%

- Check94 days agoChange DetectedRecruitment status was updated to no longer looking for participants, indicating enrollment is closed for this study. The record version was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.